Outpatient Management After Myocardial Infarction
All post-MI patients must be discharged on a mandatory four-drug regimen: aspirin (75-100 mg daily), dual antiplatelet therapy for 12 months, high-intensity statin therapy, and ACE inhibitor (or ARB if intolerant), with beta-blockers added for those with heart failure or LVEF <40%. 1
Mandatory Pharmacotherapy
Antiplatelet Therapy
- Aspirin 75-100 mg daily indefinitely is required for all post-MI patients without contraindications 1
- Dual antiplatelet therapy (DAPT) for 12 months combining aspirin plus ticagrelor or prasugrel (clopidogrel if these are unavailable or contraindicated) is mandatory after PCI 1
- For patients treated with fibrinolysis without PCI, clopidogrel for 1 month minimum is indicated, with consideration for extending to 12 months 1
- Proton pump inhibitor (PPI) must be added in patients at high risk of gastrointestinal bleeding while on DAPT 1
Lipid Management
- High-intensity statin therapy started immediately and continued long-term is required unless contraindicated 1
- Target LDL-C <1.8 mmol/L (70 mg/dL) or at least 50% reduction if baseline LDL-C is 1.8-3.5 mmol/L (70-135 mg/dL) 1
- Initiate statin therapy if LDL >130 mg/dL despite dietary modification, with goal of reducing LDL to <100 mg/dL 1, 2
Renin-Angiotensin-Aldosterone System Blockade
- ACE inhibitors are mandatory within the first 24 hours for patients with heart failure, LVEF <40%, diabetes, or anterior infarction 1
- ACE inhibitors should be continued indefinitely in all patients with LVEF <40% or heart failure 1, 2
- ARB (preferably valsartan) is the alternative for patients intolerant of ACE inhibitors with heart failure or LV systolic dysfunction 1
- Mineralocorticoid receptor antagonists (MRAs) are required in patients with ejection fraction <40% and heart failure or diabetes who are already on ACE inhibitor and beta-blocker, provided no renal failure or hyperkalemia exists 1
Beta-Blocker Therapy
- Oral beta-blockers are mandatory in patients with heart failure and/or LVEF <40% unless contraindicated 1
- Beta-blockers should be continued indefinitely after stabilization in patients with reduced ejection fraction 1, 2
- Important caveat: Recent 2024 evidence shows that in patients with preserved ejection fraction (≥50%) who underwent early coronary angiography, long-term beta-blocker treatment did not reduce mortality or reinfarction risk 3. However, guidelines still recommend beta-blockers for those with reduced LVEF or heart failure 1
Blood Pressure Management
- Target blood pressure <140/90 mmHg using lifestyle modifications and pharmacotherapy 1, 2
- In elderly, frail patients, targets can be more lenient; in very high-risk patients tolerating multiple agents, consider target <120 mmHg 1
Emergency Medication and Patient Education
Nitroglycerin Protocol
- All patients must receive sublingual or spray nitroglycerin at discharge with explicit instructions 2
- Stop all activity immediately if anginal discomfort lasts >2-3 minutes and take 1 dose of sublingual nitroglycerin 2
- Call 9-1-1 immediately if pain is unimproved or worsening after 5 minutes 2
- Patients must not be discharged without nitroglycerin and a clear emergency action plan 2
Written Instructions
- Provide written, culturally sensitive instructions including medication type, purpose, dose, frequency, and pertinent side effects 2
- Never discharge patients without written medication instructions in understandable language 2
Behavioral Modifications and Cardiac Rehabilitation
Smoking Cessation
- Identify all smokers and provide repeated cessation advice with offers of follow-up support, nicotine replacement therapies, varenicline, and bupropion individually or in combination 1, 2
- Smoking cessation is mandatory and must not be neglected 2
Cardiac Rehabilitation
- Participation in a formal cardiac rehabilitation program is mandatory 1, 2
- Patients must not be discharged without a cardiac rehabilitation referral 2
- Ultimate goal is 20 minutes of exercise at brisk walking level at least three times weekly 1
Dietary Modifications
- Diet low in saturated fat and cholesterol with reduced salt intake is required 1
- Achieve and maintain ideal body weight 1
Pre-Discharge Risk Stratification
Exercise Stress Testing
- Perform submaximal exercise testing at 4-7 days or symptom-limited testing at 10-14 days post-MI 1, 2
- Testing purposes: assess functional capacity for home/work activities, evaluate efficacy of current medical regimen, and stratify risk for subsequent cardiac events 1, 2
Echocardiography
- Routine echocardiography during hospital stay to assess LV and RV function, detect early post-MI mechanical complications, and exclude LV thrombus is required in all patients 1
Follow-Up Care Structure
Outpatient Appointments
- Low-risk patients return in 2-6 weeks; higher-risk patients return in 1-2 weeks 2
- Implement weekly telephone follow-up for the first 4 weeks after discharge to reinforce education, monitor recovery, and assess risk factor modification progress 2
Multidisciplinary Coordination
- Coordinate discharge planning with multidisciplinary team including physicians, nurses, dietitians, pharmacists, rehabilitation specialists, care managers, and physical/occupational therapists 2
Return to Activities
- Sexual activity can resume early if adjusted to physical ability 1
- Return to work decisions based on LV function, completeness of revascularization, rhythm control, and job characteristics 1
- Extended sick leave is usually not beneficial; light-to-moderate physical activity should be encouraged 1
Critical Pitfalls to Avoid
- Never discharge without ACE inhibitors in patients with reduced ejection fraction or heart failure 2
- Never omit DAPT for 12 months after PCI unless excessive bleeding risk 1
- Never discharge without clear emergency instructions for recurrent symptoms 2
- Never neglect smoking cessation counseling with pharmacotherapy offers 2
- Avoid intravenous beta-blockers in patients with hypotension, acute heart failure, AV block, or severe bradycardia 1
Adherence Optimization
- Consider fixed-dose combination (polypill) containing aspirin, ACE inhibitor, and statin to improve adherence 1
- Low treatment adherence is associated with worse outcomes; delayed outpatient follow-up results in worse medication adherence 1
- Simplify treatment regimens, provide clear information, aim for shared decision-making, and implement repetitive monitoring and feedback 1